caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1588755904

Salman FazalM.D.

PRACTICEALLEGHENY CLINICSee all providers at this practice →
Hematology-OncologyPittsburgh, PAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
407
Unique beneficiaries
—
Total services
1,182
Distinct HCPCS
8
Medicare payment
$94K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 417 Hematology-Oncology providers in PA — above median (cohort median 753).
REFERRAL NETWORK

Where Salman Fazal's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 11 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
WEST PENN ALLEGHENY HEALTH SYSTEM INC79787
David Epstein
Diagnostic Radiology · Pittsburgh, PA
2798
WEST PENN ALLEGHENY HEALTH SYSTEM INC.19430
Rishi Maheshwary
Diagnostic Radiology · Pittsburgh, PA
1753
George Bekic
Cardiology · Pittsburgh, PA
15126
SAHOVIC, ENTEZAM1575
Adrienne Vargo
Diagnostic Radiology · Saint Paul, MN
1332
David Buck
Interventional Radiology · Pittsburgh, PA
1334
Jeffrey Mueller
Diagnostic Radiology · Pittsburgh, PA
1233
Terrence Obringer
Pulmonary Disease · Monroeville, PA
1171
Mark Geller
Cardiology · Blawnox, PA
1131
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
2,279
Beneficiaries
—
Total drug cost
$10.2M
Distinct drugs
55
Brand share
40.1%
Top prescribed drugs
Acyclovir378 claims
Ruxolitinib Phosphate212 claims
Sulfamethoxazole/Trimethoprim118 claims
Ciprofloxacin Hcl117 claims
Venetoclax114 claims
QUALITY · MIPS · 2024
Final MIPS score
93.9
Quality
85.0
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.80%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$390K
Payment records
385
By payment type
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$239K
Honoraria$73K
Travel and Lodging$57K
Consulting Fee$13K
Food and Beverage$8K